NO20035647L - New use of cyclolignans and new cycloligans - Google Patents

New use of cyclolignans and new cycloligans

Info

Publication number
NO20035647L
NO20035647L NO20035647A NO20035647A NO20035647L NO 20035647 L NO20035647 L NO 20035647L NO 20035647 A NO20035647 A NO 20035647A NO 20035647 A NO20035647 A NO 20035647A NO 20035647 L NO20035647 L NO 20035647L
Authority
NO
Norway
Prior art keywords
new
cycloligans
cyclolignans
new use
new cycloligans
Prior art date
Application number
NO20035647A
Other languages
Norwegian (no)
Other versions
NO20035647D0 (en
Inventor
Olle Larsson
Magnus Axelson
Original Assignee
Axelar Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0102168A external-priority patent/SE0102168D0/en
Application filed by Axelar Ab filed Critical Axelar Ab
Publication of NO20035647D0 publication Critical patent/NO20035647D0/en
Publication of NO20035647L publication Critical patent/NO20035647L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20035647A 2001-06-19 2003-12-17 New use of cyclolignans and new cycloligans NO20035647L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0102168A SE0102168D0 (en) 2001-06-19 2001-06-19 New use and new compounds
US30043101P 2001-06-26 2001-06-26
PCT/SE2002/001223 WO2002102805A1 (en) 2001-06-19 2002-06-19 NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS

Publications (2)

Publication Number Publication Date
NO20035647D0 NO20035647D0 (en) 2003-12-17
NO20035647L true NO20035647L (en) 2004-02-18

Family

ID=26655492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035647A NO20035647L (en) 2001-06-19 2003-12-17 New use of cyclolignans and new cycloligans

Country Status (5)

Country Link
JP (1) JP2009242406A (en)
KR (1) KR20040030686A (en)
AU (2) AU2009201542B2 (en)
DE (1) DE60233601D1 (en)
NO (1) NO20035647L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100971364B1 (en) * 2009-12-28 2010-07-20 명 하 윤 Adapter for oil pressure division of excavator glove cylinder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720966B2 (en) * 1984-12-28 1995-03-08 コンプハルム・エイビ− Disease remedy containing pharmaceutically active compound
JPH09194368A (en) * 1996-01-11 1997-07-29 Pola Chem Ind Inc Podophyllotoxin derivative and new cell differentiation inducer comprising the same

Also Published As

Publication number Publication date
AU2009201542A1 (en) 2009-05-14
KR20040030686A (en) 2004-04-09
JP2009242406A (en) 2009-10-22
NO20035647D0 (en) 2003-12-17
DE60233601D1 (en) 2009-10-15
AU2010200488A1 (en) 2010-03-04
AU2009201542B2 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
NO20041272L (en) Tetracycline derivatives and methods of use thereof
NO20034187L (en) Novel spirotric cyclic derivatives and their use as phosphodiesterase-7 inhibitors
NO20033261D0 (en) New mixtures of microbial enzymes
NO20022289L (en) New use and new N-azabicycloamide derivatives
DK1417175T3 (en) SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF
NO20014495L (en) New device for oxygenation of seawater
IS7725A (en) Imidazolopyridine and methods of manufacture and use
DK1429769T3 (en) New formulations and their use
NO20014950L (en) New methods of treatment
NO20033854D0 (en) N-but-3-enyl-norbuprenorphine and methods of use
NO20024838D0 (en) Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
IS2867B (en) Neublastin-linked polymer and its methods of use
NO20041187L (en) Methods and mixtures of novel triazine compounds
ATE499096T1 (en) COMBINATION OF SEROTONIN RUPUP INHIBITORS AND AGOMELATIN
NO20041968L (en) Use of cystationin
NO20035332D0 (en) New heterocyclic derivatives and their medical use
NO20032440D0 (en) Process for the preparation of iopamidol and the novel intermediates therein
NO20031928L (en) New crystal and solvate forms of ondansetron hydrochloride and methods of preparation thereof
NO20030822L (en) New compounds and methods
NO20035331D0 (en) New heterocyclic compounds and their medical use
NO20035647L (en) New use of cyclolignans and new cycloligans
DK1429770T3 (en) New formulations and their use
NO20040479L (en) Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride.
NO20033743L (en) Process and preparation of citalopram
NO20034738D0 (en) Methods and intermediates for the preparation of benzyl peroxides